ClinConnect ClinConnect Logo
Search / Trial NCT04263337

NFL LONG Prospective Study

Launched by UNIVERSITY OF NORTH CAROLINA, CHAPEL HILL · Feb 6, 2020

Trial Information

Current as of July 22, 2025

Enrolling by invitation

Keywords

Concussion Former Nfl Players Football Neurologic Sub Concussive Exposure

ClinConnect Summary

There is growing concern that repetitive concussions, or even exposure to sub-concussive blows during collision sports, may be associated with chronic neurologic problems, including CTE. Despite the lay media attributing devastating clinical problems to CTE, no studies conclusively demonstrate a connection between the pathological findings and clinical effects. Experts at the 5th International Conference on Concussion concluded that "a cause-and-effect relationship has not yet been demonstrated between CTE and SRCs \[sport-related concussions\]" and "the notion that repeated concussion or s...

Gender

MALE

Eligibility criteria

  • Inclusion Criteria for Former NFL Player Group:
  • At least 1 year of participation in National Football League (NFL groups)
  • Retired from professional football
  • Ages between 50-70
  • Inclusion Criteria for Healthy Controls:
  • No prior exposure to football, collision sports, or prior concussions
  • They will be matched to former NFL players by age and estimated premorbid intellectual functioning.
  • Ages between 50-70
  • Exclusion Criteria:
  • Any contraindications to MRI, PET, or biological study procedures
  • History of Moderate or Severe TBI
  • Current primary Axis I diagnosis of Psychotic Disorder
  • History or clinical suspicion of other conditions (e.g., epilepsy, stroke, dementia) known to cause cognitive dysfunction
  • Diagnosis /associated treatment that would preclude participation in full study protocol (e.g., terminal cancer)

About University Of North Carolina, Chapel Hill

The University of North Carolina at Chapel Hill (UNC) is a leading research institution renowned for its commitment to advancing health and science through innovative clinical trials. With a robust infrastructure that supports multidisciplinary collaboration, UNC conducts cutting-edge research across various fields, including medicine, public health, and biomedical sciences. The university is dedicated to improving patient care and health outcomes by translating its research findings into practical applications. UNC’s clinical trials are designed to evaluate new therapies, interventions, and technologies, ensuring that they meet the highest ethical and scientific standards while fostering a culture of inclusivity and community engagement.

Locations

Milwaukee, Wisconsin, United States

Chapel Hill, North Carolina, United States

Milwaukee, Wisconsin, United States

Waltham, Massachusetts, United States

Patients applied

0 patients applied

Trial Officials

William Meehan, MD

Principal Investigator

Boston Children's Hospital

Michael McCrea, PhD

Principal Investigator

Medical College of Wisconsin

Jason Mihalik, PhD

Principal Investigator

University of North Carolina, Chapel Hill

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials